关于基于脂质的mRNA抗癌疫苗设计的考虑
Sofie Meulewaeter1, Yao Zhang2, Abishek Wadhwa3
1Laboratory of General Biochemistry and Physical Pharmacy, Faculty of Pharmaceutical Sciences, Ghent University, Ghent 9000, Belgium; Cancer Research Institute Ghent (CRIG), Ghent University Hospital, Ghent University, Ghent 9000, Belgium.
Journal of molecular biology
|December 8, 2023
概括
使者RNA (mRNA) 疫苗在癌症免疫治疗方面表现有前途,目前正在对修饰,脂质载体和输送方法进行研究,以提高癌症治疗的效力和疗效.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 由于COVID-19的刺激,信使RNA (mRNA) 疫苗技术越来越多地被用于癌症免疫疗法.
- 基于脂质的mRNA疫苗已经证明了癌症治疗的有希望的临床试验结果.
- 与传染病疫苗相比,癌症mRNA疫苗的mRNA修饰,脂质载体和施用途径存在显著差异.
研究的目的:
- 审查mRNA修饰,脂质载体和施用途径如何影响mRNA癌症疫苗的效力.
- 探索这些因素之间的相互作用,以提高癌症疫苗的有效性和安全性.
- 总结当前和新兴的提高mRNA癌症疫苗性能的策略.
主要方法:
- 关于mRNA癌症疫苗的最近临床试验和研究的文献综述.
- 分析影响mRNA疫苗功效的因素,包括脂质载体组成和向.
- 关于优化mRNA癌症疫苗疗效的策略数据的综合.
主要成果:
- 脂质载体组成可以优化,以被动向免疫细胞,从而有可能提高mRNA疫苗的疗效和安全性.
- 在mRNA修饰,脂质载体和注射途径的差异显著影响癌症疫苗的效力.
- 目前正在制定各种策略,以提高mRNA癌症疫苗的有效性.
结论:
- 优化mRNA疫苗组件和输送对于推进癌症免疫治疗至关重要.
- 对脂质载体设计和向策略的进一步研究可以改善mRNA癌症疫苗的结果.
- 下一代mRNA癌症疫苗在地平线上,提供新的治疗可能性.
相关概念视频
Cancer Vaccines
376
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
376
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K


